| Entry |
|
|---|
| Name |
Ciprofloxacin (JAN/USP/INN);
CPFX;
Cipro (TN) |
|---|
| Formula |
C17H18FN3O3
|
|---|
| Mass |
331.1332 |
|---|
| Structure |
     |
|---|
| Target |
DNA gyrase inhibitor [EC:5.99.1.3];
topoisomerase IV inhibitor [KO:K02621] [KO:K02622] |
|---|
| Metabolism |
CYP1A2 [HSA:1544] |
|---|
| Interaction |
CYP inhibitor: CYP1A2 [HSA:1544] |
|---|
| Activity |
Antibacterial |
|---|
| Remark |
Same as: C05349
Therapeutic category: 6241 7290
ATC code: J01MA02 S01AX13 S02AA15 S03AA07
 |
|---|
| Pathway |
PATH: map07014 Quinolones |
|---|
| Products |
CETRAXAL (WraSer Pharma), CIPRO (Bayer Healthcare Pharma), CIPRO (Schering-Plough), CIPRO (Schering-Plough), CIPROFLOXACIN (Akorn), CIPROFLOXACIN (Anchen Pharma), CIPROFLOXACIN (Apotex), CIPROFLOXACIN (Aurobindo Pharma), CIPROFLOXACIN (Baxter Healthcare), CIPROFLOXACIN (Dr Reddy's Lab), CIPROFLOXACIN (Hospira), CIPROFLOXACIN (SAGENT Pharma), CIPROFLOXACIN (Taro Pharma), CIPROFLOXACIN (Teva Parenteral Medicines), CIPROFLOXACIN AND DEXTROSE (Hospira), CIPROFLOXACIN HYDROCHLORIDE (Alcon Lab), Ciloxan (Alcon Lab), Ciloxan (Alcon Pharma), Ciprofloxacin (Bausch and Lomb), Ciprofloxacin (Bedford Lab), Ciprofloxacin (Cobalt Lab), Ciprofloxacin (Dr Reddy's Lab), Ciprofloxacin (Mylan Pharma), Ciprofloxacin (Teva Parenteral Medicines), Ciprofloxacin (Teva Pharma), Ciprofloxacin hydrochloride (Ivax Pharma), PROQUIN XR (Depomed), ciprofloxacin (Ranbaxy Pharma)
|
|
|---|
| Other DBs |
CAS: 85721-33-1
PubChem: 7847254
DrugBank: DB00537
PDB-CCD: CPF
LigandBox: D00186
NIKKAJI: J21.732H |
|---|
| KCF data |
 |
|---|
|
